Dostarlimab may eliminate the need for surgery in certain patients with dMMR solid tumor malignancies, a phase 2 study suggests.

neoadjuvant therapy in breast cancer, total neoadjuvant therapy in rectal cancer, and the use of biomarkers to inform ...

A WARRINGTON cancer specialist is one of three researchers at the centre of a new fundraising appeal. The Christie Charity, ...

Bristol-Myers Squibb’s Opdivo has become the first immunotherapy to be cleared for NHS use alongside chemotherapy as a pre-surgery (neoadjuvant ... therapy for resectable non-small cell lung ...

It has recently emerged as a predictor of outcome after surgery for rectal cancer. Our aim was to evaluate ... tumour site, use of neoadjuvant chemoradiation, microscopic positive resection ...

The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC ...

Q1 2025 Earnings Conference Call May 12, 2025 8:30 AM ETCompany ParticipantsZack Armen - Head of Investor RelationsGaro Armen ...

In its favour is that its drug did hit the mark when used as a neoadjuvant therapy for post-menopausal women with HR+ early breast cancer in the coopERA study, which was reported at last year's ...